We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Lägger ner utvecklingen av CicloMulsion

Ytterligare motgångar för NeuroVive. Läkemedelskandidaten CicloMulsion nådde inte primära målet i fas II.

Framtidens digitala sjukvård

Elektronisk hälsoinformatik är avgörande för utvecklingen av hälso- och sjukvård. Att investera i teknik som uppnår kostnadsbesparingar genom förbättrad patient...

Per Hammargren, Sales Director, ICU Scandinavia AB

Why are you going to Scanlab and Biotech Forum?

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Changing e-solutions for clinical trials

Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...

Mingling types - who to aim for and who to avoid:

Read about different mingling types - who are you?

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...

Så tog vi oss in på USA-marknaden

Här delar Nikolaj Sørensen, vd och koncernchef, med sig av Orexos tuffa resa att lansera läkemedel i USA.

Bactiguard installerat på börsen

Medicinteknikbolaget tog i morse steget in på Nasdaq OMX:s huvudlista.

Studie visar positiv effekt av ny kombination mot diabetes

AstraZeneca presenterar positiva resultat från fas III-studien Duration-8, på patienter med diabetes typ 2.

Fritt fram för trådlöst från Aerocrine

Får godkänt för bluetooth-version av instrumentet Niox Vero i USA.

Ny chef på Neurovive

Magnus Hansson ska leda bolagets kliniska verksamhet.

How to get the most out of the fair

Rapid system for surface hygiene monitoring

The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...

Partnering offer for scientists and medics

For the first time in the history of Biotech Forum, scientists and medics are invited to join the partnering event. I

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Oslo Cancer Cluster

Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...

Han föreslås bli Diamyds nya styrelseordförande

Efter att ett ägarkonsortium krävt att styrelsen i forskningsbolaget Diamyd byts ut läggs ett förslag på efterträdare nu fram.

Happy exhibitors!

There were fewer vistors this year but most exhibitors are content.

Syntetisera egna gener direkt på labbänken

Bioxp 3200 System från Synthetic Genomics Inc kan bygga 32 konstrukt på upp till 1,8 kilobaser i en körning.

De vill köpa Aerocrine

Brittiska Circassia erbjuder 1,78 miljarder kronor för medtechbolaget.

"An open mind is the key to successful meetings"

Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.